First GLP-1 pill approved in the European Union for the treatment of obesity and overweightOnly Wegovy® pill demonstrates 17%* mean...
Andrew P. Ambrosy, MD, MPH shares advice regarding A.I. health toolsSAN FRANCISCO, July 9, 2026 /PRNewswire/ -- The recent arrival...
Andrew P. Ambrosy, MD, MPH shares advice regarding A.I. health toolsSAN FRANCISCO, July 9, 2026 /PRNewswire/ -- The recent arrival...
Three of six SCCT 2026 Young Investigator Award-nominated abstracts utilize Caristo's technologies, including—for the first time—an application of FAI-Score on...
New prevention-focused model combines genomics, AI-powered risk assessment, personalized surveillance, and oncologist-led clinical review to identify cancer at its earliest...
New prevention-focused model combines genomics, AI-powered risk assessment, personalized surveillance, and oncologist-led clinical review to identify cancer at its earliest...
NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Originally published on CVS Health Company Newsroom Key pointsMany men...
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time...
Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) First-ever randomized, blinded, placebo-controlled trial...
New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- Zealthy, a telehealth platform that connects patients with licensed healthcare providers,...
Caristo's flagship technology, CaRi-Heart, recognised for its groundbreaking ability to transform cardiovascular disease prevention and managementCaristo joins a prestigious group...
Sublingual Compounded Vardenafil, Sildenafil, Tadalafil, and Apomorphine for Prescription ED Treatment: 10-Minute Onset and 36-Hour Active Window ResearchedKennewick, WA, June...
The same clinician-approved animations from the Hx Heart app are now available online at HxHeart.com — free, instantly, with no...
Lead asset CAD-1005 being researched for prevention of life-threatening blood clots in patients with Heparin-induced Thrombocytopenia (HIT), targets $2 billion...
– Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful reductions in blood pressure in participants...
ESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a...
DUBLIN and BRIDGEWATER, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to...
Trial liver safety data from the ‘ESSENCE’ trial confirm semaglutide's favourable hepatic profile in patients with Metabolic Dysfunction-associated Steatohepatitis (MASH),...
WOONSOCKET, RI / ACCESS Newswire / May 18, 2026 / Originally published on CVS Health Company NewsroomKey pointsAfter smoking for...
Official FDA meeting minutes and Phase 2 data provide guidance on the pivotal Phase 3 registration path for CAD-1005 in...